Strategic Partnerships BostonGene already collaborates with premier cancer centers and pharma giants, and has a recent partnership with Kyoto University. Leverage co-development and sponsored research opportunities, and offer joint-validation studies or feasibility programs to expand academic and biopharma collaborations.

AI-Driven Value The company’s foundation model and AI-driven insights are positioned to de-risk trials and accelerate target discovery. Propose pilot programs or proof-of-value engagements that quantify time-to-result reductions and improved target nomination for oncology and immunology programs.

Clinical Real-World Data With validation across extensive real-world networks and outcomes data, BostonGene can support real-world evidence generation and regulatory submissions. Seek opportunities to design RWE studies, post-market surveillance, or companion diagnostics collaborations.

Industry Recognition Recent awards and high-profile publications bolster credibility. Use these accolades in joint marketing, capability briefings, and competitive positioning to win larger multi-project deals or strategic partnerships with pharma portfolios seeking AI-based precision oncology solutions.

Global Expansion Active global engagement evidenced by awards and conferences, plus a Kyoto University partnership signals readiness for international collaborations. Propose regional hubs, co-development units, or multi-national clinical programs to scale deployment and access new markets.